Disclosed on November 26, Steven H Collis, Executive Chairman at Cencora COR, executed a substantial insider sell as per the latest SEC filing. What Happened: Collis opted to sell 50,000 shares of ...

Monday, November 25, 2024 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Costco ...

Indian drugmaker Lupin is recalling more than 600,000 bottles of the high blood pressure and heart failure drug ramipril due ...

Fintel reports that on November 22, 2024, Wells Fargo initiated coverage of Amphastar Pharmaceuticals (NasdaqGS:AMPH) with a ...

Oz’s financial disclosures from his Senate run in 2022 reveal that he and his wife owned shares in several pharmaceutical ...

As the biopharma industry braces for a second term under President-elect Donald Trump, speculation is swirling around the ...

The venerable S&P 500 is poised for another year of 20% + gains Many of the stocks in the index have underperformed the ...

Two pharmaceutical giants were ordered to pay ... liable for $192 million in damages and Pennsylvania-based drug wholesaler Cencora for $74 million. Baltimore accused the companies of failing ...

WEST CHESTER, Pa., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics ...

Small tweaks to tax policy and the deficit policy won’t solve the problem. “It is about wholesale change and we as humans, we are sometimes scared of wholesale change,” he said. An advantage ...

To support demand for consumer health products, Cardinal Health's new facility will be the central replenishment center for over-the-counter consumer health products.